Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: J Hepatol. 2011 Feb 18;55(4):838–845. doi: 10.1016/j.jhep.2010.12.043

Figure 1. Flow cytometric analysis of hepatoma cells.

Figure 1

A. CD133+/ALDHhigh cells in Hepatoma cell lines. B. CD133+/EpCAM+ cells in hepatoma cell lines. CD133+/ALDHhigh and CD133−/ALDHlow or CD133+/EpCAM+ and CD133−/EpCAM− cells were separated by FACS after staining with APC-conjugated anti-CD133 antibody and an Adelfluor kit (A) or with APC-conjugated anti-CD133 and FITC-conjugated anti-EpCAM antibodies (B).

HHS Vulnerability Disclosure